Reflux Esophagitis (RE)

Reflux Esophagitis (RE) is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Reflux Esophagitis · Esophagitis, Reflux · Reflux Oesophagitis

Resolves to

Vocabularies
MeSHT015095ICD-10K21SNOMED CT155673008MedDRA10017885UMLSC0014869

What you can answer from here — as of November 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
37Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Reflux Esophagitis (RE) share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.

Create Account